PubRank

Gregory I Liou

Author PubWeight™ 29.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J Exp Med 2006 3.20
2 Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets 2005 1.98
3 Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol 2006 1.77
4 Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 2008 1.59
5 An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms. J Exp Med 2003 1.44
6 Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity. J Exp Med 2006 1.34
7 Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes 2011 1.31
8 Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. Am J Pathol 2003 1.30
9 Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice. Invest Ophthalmol Vis Sci 2008 1.09
10 Exaggerated eye growth in IRBP-deficient mice in early development. Invest Ophthalmol Vis Sci 2011 1.07
11 Receptor interacting protein kinase-mediated necrosis contributes to cone and rod photoreceptor degeneration in the retina lacking interphotoreceptor retinoid-binding protein. J Neurosci 2013 1.02
12 Normal cone function requires the interphotoreceptor retinoid binding protein. J Neurosci 2009 1.01
13 Role of IL-6 in angiotensin II-induced retinal vascular inflammation. Invest Ophthalmol Vis Sci 2009 0.97
14 Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol Vis 2010 0.95
15 NAD(P)H oxidase-dependent regulation of CCL2 production during retinal inflammation. Invest Ophthalmol Vis Sci 2009 0.92
16 Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma. Ophthalmic Res 2007 0.91
17 Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice. Vascul Pharmacol 2011 0.90
18 Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-α in the retina. Invest Ophthalmol Vis Sci 2011 0.90
19 Interphotoreceptor retinoid-binding protein (IRBP)-deficient C57BL/6 mice have enhanced immunological and immunopathogenic responses to IRBP and an altered recognition of IRBP epitopes. J Autoimmun 2003 0.88
20 A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy. Am J Pathol 2011 0.86
21 Potential roles of adenosine deaminase-2 in diabetic retinopathy. Biochem Biophys Res Commun 2013 0.84
22 Loss of thioredoxin function in retinas of mice overexpressing amyloid β. Free Radic Biol Med 2012 0.83
23 ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy. Life Sci 2013 0.82
24 Potential role of A2A adenosine receptor in traumatic optic neuropathy. J Neuroimmunol 2013 0.82
25 Regulation of vitamin C transporter in the type 1 diabetic mouse bone and bone marrow. Exp Mol Pathol 2013 0.80
26 Sequence analysis of the mouse IRBP gene and cDNA. Curr Eye Res 2002 0.78